Asia Green Biotechnology (XCNQ:ASIA) EV-to-EBIT : -7.39 (As of May. 21, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Asia Green Biotechnology's Enterprise Value is C$0.79 Mil. Asia Green Biotechnology's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.11 Mil. Therefore, Asia Green Biotechnology's EV-to-EBIT for today is -7.39.

The historical rank and industry rank for Asia Green Biotechnology's EV-to-EBIT or its related term are showing as below:

XCNQ:ASIA' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.21 Med: 0 Max: 0
Current: -7.39

XCNQ:ASIA's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.86 vs XCNQ:ASIA: -7.39

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Asia Green Biotechnology's Enterprise Value for the quarter that ended in Sep. 2023 was C$0.61 Mil. Asia Green Biotechnology's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.11 Mil. Asia Green Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -17.53%.

Asia Green Biotechnology EV-to-EBIT Historical Data

The historical data trend for Asia Green Biotechnology's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology EV-to-EBIT Chart

Asia Green Biotechnology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

-1.09

-5.54

-2.93

-4.23

Asia Green Biotechnology Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial															-4.14	-4.23	-6.66	-7.65	-5.71

Competitive Comparison of Asia Green Biotechnology's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asia Green Biotechnology's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's EV-to-EBIT falls into.

Asia Green Biotechnology EV-to-EBIT Calculation

Asia Green Biotechnology's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.791	/	-0.107
	=	-7.39

Asia Green Biotechnology's current Enterprise Value is C$0.79 Mil.
Asia Green Biotechnology's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

Asia Green Biotechnology (XCNQ:ASIA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Asia Green Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	-0.107	/	0.610471
	=	-17.53 %

Asia Green Biotechnology's Enterprise Value for the quarter that ended in Sep. 2023 was C$0.61 Mil.
Asia Green Biotechnology's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.11 Mil.

Asia Green Biotechnology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Asia Green Biotechnology (XCNQ:ASIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.asiagreenbiotechnology.com

Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Asia Green Biotechnology (XCNQ:ASIA) Headlines

No Headlines